Largest health care companies by earnings
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Johnson & Johnson leads the 170 health care companies ranked by earnings, at CZK 596.4B, ahead of Eli Lilly (CZK 459.2B) and Merck & Co (CZK 406.2B). Figures as of 19 Nov 2026, 16:37 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 170
- First
- Johnson & JohnsonCZK 596.4B
- Median
- CZK 6.1B
- Combined market value
- CZK 199.36T
- Countries
- 14
Market values as of .
All countries▾
Health Care▾
All categories▾
| # | Company | Earnings ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 101 | Hims & Hers HealthHIMS · Health Care | CZK 2.9B | CZK 86.5B | CZK 368.80 | 2.79% down | 49% down | ||
| 102 | Ligand PharmaceuticalsLGND · Health Care | CZK 2.8B | CZK 130.1B | CZK 6,502.79 | 2.16% down | 50% up | ||
| 103 | Corcept TherapeuticsCORT · Health Care | CZK 2.2B | CZK 160.3B | CZK 1,464.29 | 2.92% down | 10% down | ||
| 104 | HaemoneticsHAE · Health Care | CZK 2.2B | CZK 121.9B | CZK 2,676.03 | 2.11% down | 64% up | ||
| 105 | Amneal PharmaceuticalsAMRX · Health Care | CZK 1.6B | CZK 166.8B | CZK 478.82 | 1.65% down | 90% up | ||
| 106 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | CZK 1.3B | CZK 166.6B | CZK 2,120.44 | 0.26% up | 129% up | ||
| 107 | RepligenRGEN · Health Care | CZK 1.1B | CZK 250.4B | CZK 3,917.37 | 1.96% up | 12% up | ||
| 108 | LifeStance Health GroupLFST · Health Care | CZK 215M | CZK 113.3B | CZK 298.04 | 2.72% down | 123% up | ||
| 109 | BillionToOneBLLN · Health Care | CZK 165.9M | CZK 97.4B | CZK 2,039.56 | 0.14% up | 4% down | ||
| 110 | Arrowhead PharmaceuticalsARWR · Health Care | -CZK 36.3M | CZK 137.4B | CZK 971.67 | 1.30% up | 13% up | ||
| 111 | BrukerBRKR · Health Care | -CZK 191.4M | CZK 220.6B | CZK 1,444.71 | 2.64% up | 44% up | ||
| 112 | RadNetRDNT · Health Care | -CZK 415M | CZK 122.6B | CZK 1,555.85 | 2.64% down | 9% down | ||
| 113 | Mirum PharmaceuticalsMIRM · Health Care | -CZK 519.8M | CZK 138.3B | CZK 2,118.44 | 2.94% up | 34% up | ||
| 114 | Travere TherapeuticsTVTX · Health Care | -CZK 568.4M | CZK 106.2B | CZK 1,106.17 | 1.04% down | 45% up | ||
| 115 | 10x GenomicsTXG · Health Care | -CZK 968.9M | CZK 178.9B | CZK 1,359.93 | 7.10% up | 247% up | ||
| 116 | Adaptive BiotechnologiesADPT · Health Care | -CZK 1.3B | CZK 106.5B | CZK 657.94 | 3.90% up | 74% up | ||
| 117 | Caris Life SciencesCAI · Health Care | -CZK 1.5B | CZK 126.4B | CZK 440.78 | 1.59% up | 19% down | ||
| 118 | VeradermicsMANE · Health Care | -CZK 1.6B | CZK 117B | CZK 2,773.26 | 0.18% down | 231% up | ||
| 119 | Belite BioBLTE · Health Care | -CZK 1.7B | CZK 139.6B | CZK 3,437.66 | 1.11% down | 43% up | ||
| 120 | Twist BioscienceTWST · Health Care | -CZK 1.7B | CZK 184.3B | CZK 2,702.62 | 4.40% up | 346% up | ||
| 121 | Oruka TherapeuticsORKA · Health Care | -CZK 2.3B | CZK 149.7B | CZK 2,207.22 | 3.61% up | 255% up | ||
| 122 | HeartflowHTFL · Health Care | -CZK 2.6B | CZK 90.2B | CZK 1,026.85 | 0.57% up | 66% up | ||
| 123 | ErascaERAS · Health Care | -CZK 2.8B | CZK 112.1B | CZK 319.29 | 4.29% up | 395% up | ||
| 124 | Protagonist TherapeuticsPTGX · Health Care | -CZK 2.9B | CZK 184.4B | CZK 2,825.11 | 0.15% down | 51% up | ||
| 125 | Charles River Laboratories InternationalCRL · Health Care | -CZK 3.2B | CZK 359.7B | CZK 7,505.88 | 1.23% up | 106% up | ||
| 126 | Spyre TherapeuticsSYRE · Health Care | -CZK 3.5B | CZK 210.2B | CZK 2,213.45 | 1.95% down | 332% up | ||
| 127 | CG OncologyCGON · Health Care | -CZK 3.6B | CZK 163.6B | CZK 1,831.86 | 2.91% up | 97% up | ||
| 128 | Dianthus TherapeuticsDNTH · Health Care | -CZK 3.6B | CZK 107.8B | CZK 1,914.85 | 2.48% up | 108% up | ||
| 129 | Edgewise TherapeuticsEWTX · Health Care | -CZK 3.7B | CZK 100.6B | CZK 918.49 | 0.22% down | 86% up | ||
| 130 | Axsome TherapeuticsAXSM · Health Care | -CZK 4.1B | CZK 157.6B | CZK 2,995.32 | 0.46% up | 6% down | ||
| 131 | Definium TherapeuticsDFTX · Health Care | -CZK 4.1B | CZK 87.9B | CZK 642.03 | 0.91% down | 168% up | ||
| 132 | GlaukosGKOS · Health Care | -CZK 4.2B | CZK 310.4B | CZK 5,243.04 | 1.10% up | 145% up | ||
| 133 | Rhythm PharmaceuticalsRYTM · Health Care | -CZK 4.4B | CZK 181.6B | CZK 2,619.96 | 1.08% down | 18% up | ||
| 134 | NateraNTRA · Health Care | -CZK 4.6B | CZK 970.3B | CZK 6,691.30 | 3.88% up | 28% up | ||
| 135 | Kodiak SciencesKOD · Health Care | -CZK 5.1B | CZK 143.9B | CZK 2,200.10 | 1.09% up | 399% up | ||
| 136 | Elanco Animal HealthELAN · Health Care | -CZK 5.2B | CZK 296.5B | CZK 593.30 | 0.13% down | 26% up | ||
| 137 | LivaNovaLIVN · Health Care | -CZK 5.4B | CZK 113.6B | CZK 2,062.37 | 1.96% down | 77% up | ||
| 138 | Ascendis PharmaASND · Health Care | -CZK 5.6B | CZK 388.4B | CZK 5,921.45 | 1.55% down | 29% up | ||
| 139 | Madrigal PharmaceuticalsMDGL · Health Care | -CZK 6.4B | CZK 209.9B | CZK 9,036.70 | 2.02% up | 27% down | ||
| 140 | Legend BiotechLEGN · Health Care | -CZK 6.6B | CZK 70.5B | CZK 363.57 | 0.55% up | 41% down | ||
| 141 | Roivant SciencesROIV · Health Care | -CZK 6.7B | CZK 638.7B | CZK 881.44 | 2.29% up | 91% up | ||
| 142 | Praxis Precision MedicinesPRAX · Health Care | -CZK 6.7B | CZK 198.4B | CZK 7,096.26 | 4.50% up | 86% up | ||
| 143 | Kymera TherapeuticsKYMR · Health Care | -CZK 6.9B | CZK 226.6B | CZK 2,653.78 | 1.54% down | 87% up | ||
| 144 | Cogent BiosciencesCOGT · Health Care | -CZK 7.3B | CZK 109B | CZK 626.34 | 1.22% up | 20% down | ||
| 145 | MiniMed GroupMMED · Health Care | -CZK 7.4B | CZK 101.9B | CZK 362.34 | 4.15% down | 8% down | ||
| 146 | ImmunityBioIBRX · Health Care | -CZK 7.8B | CZK 159.3B | CZK 149.74 | 0.45% up | 232% up | ||
| 147 | Jazz PharmaceuticalsJAZZ · Health Care | -CZK 7.9B | CZK 344.6B | CZK 5,368.75 | 2.62% down | 41% up | ||
| 148 | Bausch + LombBLCO · Health Care | -CZK 8B | CZK 165.7B | CZK 463.47 | 0.57% down | 44% up | ||
| 149 | ABIVAXABVX · Health Care | -CZK 8.3B | CZK 163.3B | CZK 1,865.01 | 0.01% down | 32% down | ||
| 150 | Scholar Rock HoldingSRRK · Health Care | -CZK 8.4B | CZK 135.7B | CZK 1,112.51 | 4.17% up | 26% up | ||
| 151 | Ionis PharmaceuticalsIONS · Health Care | -CZK 8.5B | CZK 100.9B | CZK 605.76 | 0.60% down | 63% down | ||
| 152 | GRAILGRAL · Health Care | -CZK 9.1B | CZK 110.5B | CZK 2,458.31 | 8.21% up | 19% up | ||
| 153 | Guardant HealthGH · Health Care | -CZK 9.3B | CZK 456.2B | CZK 3,372.02 | 4.42% up | 45% up | ||
| 154 | Oscar HealthOSCR · Health Care | -CZK 9.9B | CZK 186.2B | CZK 599.31 | 2.30% down | 112% up | ||
| 155 | ImmunovantIMVT · Health Care | -CZK 11.2B | CZK 152.6B | CZK 737.37 | 0.09% down | 46% up | ||
| 156 | AvantorAVTR · Health Care | -CZK 11.8B | CZK 230.6B | CZK 340.32 | 0.49% down | 40% up | ||
| 157 | CRISPR TherapeuticsCRSP · Health Care | -CZK 12.9B | CZK 87.7B | CZK 904.14 | 1.11% up | 18% down | ||
| 158 | BridgeBio PharmaBBIO · Health Care | -CZK 16.3B | CZK 341.5B | CZK 1,753.04 | 1.00% up | 21% up | ||
| 159 | VaxcytePCVX · Health Care | -CZK 17.1B | CZK 210.6B | CZK 1,330.34 | 2.17% up | 23% up | ||
| 160 | CytokineticsCYTK · Health Care | -CZK 17.5B | CZK 159.5B | CZK 1,144.66 | 0.24% up | 19% down | ||
| 161 | TeleflexTFX · Health Care | -CZK 20.2B | CZK 144.5B | CZK 3,643.36 | 1.27% down | 58% up | ||
| 162 | Takeda PharmaceuticalTAK · Health Care | -CZK 21.2B | CZK 1.52T | CZK 475.04 | 0.38% up | 51% up | ||
| 163 | Baxter InternationalBAX · Health Care | -CZK 21.3B | CZK 292.4B | CZK 565.27 | 2.89% down | 50% up | ||
| 164 | Summit TherapeuticsSMMT · Health Care | -CZK 24B | CZK 191.9B | CZK 239.97 | 2.71% up | 36% down | ||
| 165 | Revolution MedicinesRVMD · Health Care | -CZK 25.2B | CZK 788.4B | CZK 3,645.03 | 2.50% up | 129% up | ||
| 166 | BioNTechBNTX · Health Care | -CZK 28B | CZK 454.7B | CZK 1,834.08 | 1.00% down | 14% down | ||
| 167 | InsmedINSM · Health Care | -CZK 28.4B | CZK 709.1B | CZK 3,232.29 | 21.26% up | 40% down | ||
| 168 | ModernaMRNA · Health Care | -CZK 62.8B | CZK 1.81T | CZK 4,462.28 | 1.91% up | 780% up | ||
| 169 | ViatrisVTRS · Health Care | -CZK 78.2B | CZK 508.1B | CZK 443.22 | 1.78% down | 99% up | ||
| 170 | CenteneCNC · Health Care | -CZK 148.5B | CZK 711.8B | CZK 1,437.81 | 4.20% down | 94% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Earnings is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 22.2502 CZK).
Questions and answers
Which health care companies rank first by earnings?
Johnson & Johnson (CZK 596.4B), Eli Lilly (CZK 459.2B) and Merck & Co (CZK 406.2B) are the top three of the 170 health care companies ranked by earnings as of 19 Nov 2026, 16:37 UTC.
How many health care companies are in this ranking?
170 are ranked by earnings.
What are these health care companies worth together?
The 170 health care companies ranked by earnings have a combined market value of CZK 199.36T as of 19 Nov 2026, 16:37 UTC.
What does ranking by earnings measure?
Net income for the latest fiscal year: what was left for shareholders after every cost, interest and tax. A negative figure is a loss.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest health care companies by earnings”, data as of 19 November 2026. https://funkfolio.com/companies/sector/health-care?by=earnings
Underlying data: Yahoo Finance; SEC EDGAR.